Fig. 4. Association of 1–2 vs ≥3 SABA prescriptions (both without SABA OTC purchase) with the level of asthma control assessed during the study visit and severe exacerbations in the 12 months before the study visit in the SABINA III study population included in this analysis (N = 4556).

CI confidence interval, IRR incidence rate ratio, OR odds ratio, OTC over-the-counter, SABA short-acting β₂-agonist, SABINA SABA use IN Asthma.